In accordance with ACR pointers, allopurinol is strongly advisable as a first-line urate-reducing medication. Genetic tests is usually recommended (for a variant referred to as HLA B*5801) ahead of starting off allopurinol because the carriers of the gene are at an elevated chance of the critical al